135 related articles for article (PubMed ID: 2006715)
61. Effect of DNA ploidy classification on prognosis in breast cancer.
Joensuu H; Alanen K; Falkmer UG; Klemi P; Nordling S; Remvikos Y; Toikkanen S
Int J Cancer; 1992 Nov; 52(5):701-6. PubMed ID: 1428229
[TBL] [Abstract][Full Text] [Related]
62. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
Bergers E; Baak JP; van Diest PJ; Willig AJ; Los J; Peterse JL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH
Mod Pathol; 1997 Aug; 10(8):762-8. PubMed ID: 9267817
[TBL] [Abstract][Full Text] [Related]
63. Microvessel quantitation and prognosis in invasive breast carcinoma.
Bosari S; Lee AK; DeLellis RA; Wiley BD; Heatley GJ; Silverman ML
Hum Pathol; 1992 Jul; 23(7):755-61. PubMed ID: 1377162
[TBL] [Abstract][Full Text] [Related]
64. DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.
Pedersen L; Larsen JK; Christensen IJ; Lykkesfeldt A; Holck S; Schiødt T
Breast Cancer Res Treat; 1994; 29(3):297-306. PubMed ID: 8049463
[TBL] [Abstract][Full Text] [Related]
65. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
66. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
67. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.
Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M
Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982
[TBL] [Abstract][Full Text] [Related]
68. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
Redkar AA; Balsara BR; Bhisey AN; Sampat MB; Mittra I
Indian J Med Res; 1992 Aug; 96():223-9. PubMed ID: 1428060
[TBL] [Abstract][Full Text] [Related]
69. Grade and flow cytometric analysis of ploidy for infiltrating ductal carcinomas.
Frierson HF
Hum Pathol; 1993 Jan; 24(1):24-9. PubMed ID: 8380276
[TBL] [Abstract][Full Text] [Related]
70. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
[TBL] [Abstract][Full Text] [Related]
71. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
[TBL] [Abstract][Full Text] [Related]
72. Flow cytometric analysis of DNA ploidy and S-phase fraction in breast cancer using cells obtained by ex vivo fine-needle aspiration: an optimal method for sample collection.
Eliasen CA; Opitz LM; Vamvakas EC; Espiritu EC; Marsh ER; Roses DF; Harris MN; Feiner HD
Mod Pathol; 1991 Mar; 4(2):196-200. PubMed ID: 2047382
[TBL] [Abstract][Full Text] [Related]
73. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
74. Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer.
Feichter GE; Mueller A; Kaufmann M; Haag D; Born IA; Abel U; Klinga K; Kubli F; Goerttler K
Int J Cancer; 1988 Jun; 41(6):823-8. PubMed ID: 3372059
[TBL] [Abstract][Full Text] [Related]
75. Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
Green RW; Engblom S; Baldetorp B; Hartman L; Måsbäck A; Bjurberg M
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1064-73. PubMed ID: 26123703
[TBL] [Abstract][Full Text] [Related]
76. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
Chen TL; Luo I; Mikhail N; Rasková J; Raska K
Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
[TBL] [Abstract][Full Text] [Related]
77. A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinomas: an objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single-tube assay.
Leers MP; Schutte B; Theunissen PH; Ramaekers FC; Nap M
Hum Pathol; 2000 May; 31(5):584-92. PubMed ID: 10836298
[TBL] [Abstract][Full Text] [Related]
78. Intratumoral variations in DNA ploidy and s-phase fraction in human breast cancer.
Arnerlöv C; Emdin SO; Cajander S; Bengtsson NO; Tavelin B; Roos G
Anal Cell Pathol; 2001; 23(1):21-8. PubMed ID: 11790856
[TBL] [Abstract][Full Text] [Related]
79. Expression of the 85-kd membrane protein in primary human breast cancer: relationship to hormone receptor levels, DNA ploidy, and tumor grade.
de la Torre M; Nygren P; Larsson R; Lindgren A; Tsuruo T; Bergh J
Hum Pathol; 1995 Feb; 26(2):180-5. PubMed ID: 7532148
[TBL] [Abstract][Full Text] [Related]
80. Relationships between nodal status and cell kinetics, DNA ploidy pattern and histopathology of the deeply infiltrating sites in colorectal adenocarcinoma.
Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
Acta Pathol Jpn; 1993 Oct; 43(10):590-6. PubMed ID: 8291447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
